[HTML][HTML] T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector
I Fert, L Douguet, B Vesin, F Moncoq, A Noirat, P Authié… - npj Vaccines, 2024 - nature.com
We recently developed an immuno-oncotherapy against human papillomavirus (HPV)-
induced tumors based on a lentiviral vector encoding the Early E6 and E7 oncoproteins of …
induced tumors based on a lentiviral vector encoding the Early E6 and E7 oncoproteins of …
Differential predictive value of resident memory CD8+ T cell subpopulations in non-small-cell lung cancer patients treated by immunotherapy
L Paolini, T Tran, S Corgnac, JP VILLEMIN, M Wislez… - bioRxiv, 2024 - biorxiv.org
A high density of resident memory T cells (TRM) in tumors correlates with improved clinical
outcomes in immunotherapy-treated patients. However, in preclinical models, only some …
outcomes in immunotherapy-treated patients. However, in preclinical models, only some …
The Development of Therapeutic HPV Vaccines to Eradicate Cervical Cancer
C Beeson - jmsgr.tamhsc.edu
Background: Persistent high risk genital Human Papillomavirus (HPV) infections are the
cause of 99.7% of cervical cancer cases. 1 While there has been a growing availability of the …
cause of 99.7% of cervical cancer cases. 1 While there has been a growing availability of the …